<DOC>
	<DOCNO>NCT00444470</DOCNO>
	<brief_summary>Spinal fusion surgery associate significant blood loss require allogeneic blood transfusion . Tranexamic acid synthetic amino acid antifibrinolytic action show reduce perioperative blood loss patient undergoing cardiopulmonary bypass cardiac bypass surgery , knee replacement liver transplantation surgery . The efficacy antifibrinolytics reduction blood loss major spine surgery well study adult patient . The objective study determine efficacy tranexamic acid reduce perioperative blood loss blood transfusion adult undergo elective spinal fusion large , multi-centered , randomize , double-blinded , placebo control trial .</brief_summary>
	<brief_title>Safety Tranexamic Acid Reducing Bleeding Adults Undergoing Spinal Surgery</brief_title>
	<detailed_description>Spinal fusion associate significant blood loss require allogeneic blood transfusion ( ABT ) . Ongoing concern cost , risk , availability allogeneic blood prompt implementation multiple technique ( preoperative erythropoetin , autologous pre-donation , intra-operative blood salvage , induced hypotension ) reduce necessity ABT . However , 28 % patient undergoing spinal fusion Toronto Western Hospital still receive ABT . Also , none modality ( exception induce hypotension ) actually reduce amount blood shed surgical wound ; thus severity anemia largely unaffected . Consequently , many patient suffer adverse effect anemia postoperatively well potential complication blood transfusion . The underlying assumption propose study excessive fibrinolysis occur spinal fusion surgery . This result increase recurrent blood loss , exacerbate significant amount bleed already associate major spine surgery . Tranexamic acid - antifibrinolytic drug block dissolution hemostatic fibrin , stabilize fibrin structure , thus may decrease blood loss secondary increase fibrinolysis . This research proposal test follow hypothesis : 1 . Tranexamic acid reduces estimate perioperative blood loss adult patient undergo elective spinal fusion . 2 . Tranexamic acid reduces need blood transfusion adult patient undergo elective spinal fusion . This multi-centered trial valuable establish efficacy safety tranexamic acid reduce blood loss allogeneic blood transfusion adult elective spinal fusion . Tranexamic acid easy administer , relatively inexpensive , associated significant adverse effect . If show efficacious , incorporated routine clinical practice part multi-modal perioperative blood conservation technique currently use reduce perioperative blood loss , transfusion risk allogeneic blood transfusion .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All adult patient ( great 18 year old ) undergo elective posterior thoracic/lumbar instrument spinal fusion . Participation another clinical trial Allergy TA Spinal tumor/Intradural pathology Ankylosing spondylitis Acquired disturbances color vision Preoperative anemia ( Hb &lt; 110 female , Hb &lt; 120 male ) Refusal blood product ( Jehovah 's witness ) Preoperative use anticoagulant therapy coumadin , heparin within 5 day surgery Fibrinolytic disorder require intraoperative antifibrinolytic treatment Hematological disease ( thromboembolic event , hemoglobinopathy , coagulopathy hemolytic disease ) Preoperative platelet count &lt; 150,000/cubic mm , INR &gt; 1.4 , prolong PTT Significant comorbidities : Previous MI ; severe ischemic heart disease ( NYHA Class III , IV ) ; severe pulmonary disease ; chronic renal failure ; hepatic failure ; uncontrolled hypertension Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>spine surgery</keyword>
	<keyword>spinal fusion decompression</keyword>
	<keyword>adult</keyword>
	<keyword>perioperative</keyword>
	<keyword>blood loss</keyword>
	<keyword>bleeding</keyword>
	<keyword>blood transfusion</keyword>
</DOC>